BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38828722)

  • 41. [Clonal hematopoiesis: causes and clinical implications].
    Burchert A
    Inn Med (Heidelb); 2022 Oct; 63(10):1051-1058. PubMed ID: 35969263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
    Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
    ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
    Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
    Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease.
    Amorós-Pérez M; Fuster JJ
    Atherosclerosis; 2020 Mar; 297():120-126. PubMed ID: 32109665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.
    Nakauchi Y; Azizi A; Thomas D; Corces MR; Reinisch A; Sharma R; Cruz Hernandez D; Köhnke T; Karigane D; Fan A; Martinez-Krams D; Stafford M; Kaur S; Dutta R; Phan P; Ediriwickrema A; McCarthy E; Ning Y; Phillips T; Ellison CK; Guler GD; Bergamaschi A; Ku CJ; Levy S; Majeti R
    Blood Cancer Discov; 2022 Jul; 3(4):346-367. PubMed ID: 35532363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
    Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
    Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.
    Jaiswal S; Libby P
    Nat Rev Cardiol; 2020 Mar; 17(3):137-144. PubMed ID: 31406340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
    Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
    J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consequences of mutant TET2 on clonality and subclonal hierarchy.
    Hirsch CM; Nazha A; Kneen K; Abazeed ME; Meggendorfer M; Przychodzen BP; Nadarajah N; Adema V; Nagata Y; Goyal A; Awada H; Asad MF; Visconte V; Guan Y; Sekeres MA; Olinski R; Jha BK; LaFramboise T; Radivoyevitch T; Haferlach T; Maciejewski JP
    Leukemia; 2018 Aug; 32(8):1751-1761. PubMed ID: 29795413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
    Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
    Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells.
    Schoeler K; Aufschnaiter A; Messner S; Derudder E; Herzog S; Villunger A; Rajewsky K; Labi V
    FEBS J; 2019 Sep; 286(18):3566-3581. PubMed ID: 31120187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
    Haybar H; Shahrabi S; Ghanavat M; Khodadi E
    J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clonal haematopoiesis: A concise review].
    Danlos FX; Papo M; Micol JB
    Rev Med Interne; 2019 Oct; 40(10):684-692. PubMed ID: 31126662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury.
    Vlasschaert C; Robinson-Cohen C; Chen J; Akwo E; Parker AC; Silver SA; Bhatraju PK; Poisner H; Cao S; Jiang M; Wang Y; Niu A; Siew E; Van Amburg JC; Kramer HJ; Kottgen A; Franceschini N; Psaty BM; Tracy RP; Alonso A; Arking DE; Coresh J; Ballantyne CM; Boerwinkle E; Grams M; Zhang MZ; Kestenbaum B; Lanktree MB; Rauh MJ; Harris RC; Bick AG
    Nat Med; 2024 Mar; 30(3):810-817. PubMed ID: 38454125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence of Clonal Hematopoiesis and Risk of Heart Failure.
    Bazeley P; Morales R; Tang WHW
    Curr Heart Fail Rep; 2020 Oct; 17(5):271-276. PubMed ID: 32772279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in
    Yalcinkaya M; Liu W; Thomas LA; Olszewska M; Xiao T; Abramowicz S; Papapetrou EP; Westerterp M; Wang N; Tabas I; Tall AR
    Circulation; 2023 Nov; 148(22):1764-1777. PubMed ID: 37781816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
    Marshall CH; Gondek LP; Luo J; Antonarakis ES
    Cancer Res; 2022 Nov; 82(22):4107-4113. PubMed ID: 36040522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.
    Minor EA; Court BL; Young JI; Wang G
    J Biol Chem; 2013 May; 288(19):13669-74. PubMed ID: 23548903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.